Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Haematologica|May 13, 2017
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndromeSa A Wang, Robert P Hasserjian, Wayne Tam, et al.
Ejhaem|January 27, 2025
Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56-positive acute leukemiasHanan Hamdan, Yen-Chun Liu, Sa A Wang, et al.
American Journal of Hematology|October 18, 2025
Acute Leukemias of Ambiguous Lineage With RUNX1 Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With RUNX1 Mutations: A Study From the Bone Marrow Pathology GroupTimothy J Kirtek, Weina Chen, Jaryse C Harris, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology GroupOlga K Weinberg, Karen M Chisholm, Chi Young Ok, et al.
BMC Cancer|August 20, 2016
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort studyDavid P Steensma, Medrdad Abedi, Rafael Bejar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2016
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specifiedSa A Wang, Wayne Tam, Albert G Tsai, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 15, 2021
Myeloid/lymphoid neoplasms with FLT3 rearrangementGuilin Tang, Wayne Tam, Nicholas J Short, et al.
Haematologica|January 28, 2014
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group studyHeesun J Rogers, James W Vardiman, John Anastasi, et al.
Human Pathology|June 19, 2026
Evaluation of Prognostic Factors and Outcomes in Primary versus Secondary Myeloid SarcomaChristine W Kahlow, Sharon Germans, Maximiliano Ramia de Cap, et al.
American Journal of Hematology|July 22, 2014
De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group studyRobert Paul Hasserjian, Federico Campigotto, Veronica Klepeis, et al.
Pageof 5